BRPI0418052A2 - derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1 - Google Patents

derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1

Info

Publication number: BRPI0418052A2
Authority: BR; Brazil
Prior art keywords: spherocyclic; receptor affinity; cyclohexane derivatives; orl1 receptor; orl1
Prior art date: 2003-12-23

Application number

BRPI0418052A

Other languages

English (en)

Inventor

Yvonne Kogel Babette

Merla Beatrix

Sundermann Bernd

Henkel Birgitta

Hinze Claudia

Saunders Derek

Friderichs Elmar

Schick Hans

Linz Klaus

Oberbörsch Stefan

Frormann Sven

Gunter Englberger Werner

Schroder Wolfgang

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-21

Publication date

2017-04-18

2004-12-21 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2017-04-18 Publication of BRPI0418052A2 publication Critical patent/BRPI0418052A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0418052A 2003-12-23 2004-12-21 derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1 BRPI0418052A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10360792A DE10360792A1 (de)	2003-12-23	2003-12-23	Spirocyclische Cyclohexan-Derivate
PCT/EP2004/014539 WO2005066183A1 (de)	2003-12-23	2004-12-21	Spirocyclische cyclohexan-derivate mit affinität zum orl1-rezeptor

Publications (1)

Publication Number	Publication Date
BRPI0418052A2 true BRPI0418052A2 (pt)	2017-04-18

Family

ID=34706497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0418052A BRPI0418052A2 (pt)	2003-12-23	2004-12-21	derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1

Country Status (28)

Country	Link
US (1)	US7332519B2 (pt)
EP (1)	EP1725567B1 (pt)
JP (1)	JP4885733B2 (pt)
KR (1)	KR101152693B1 (pt)
CN (1)	CN1922189B (pt)
AR (1)	AR047163A1 (pt)
AT (1)	ATE390430T1 (pt)
AU (1)	AU2004312147B2 (pt)
BR (1)	BRPI0418052A2 (pt)
CA (1)	CA2550868C (pt)
CY (1)	CY1107975T1 (pt)
DE (2)	DE10360792A1 (pt)
DK (1)	DK1725567T3 (pt)
EC (1)	ECSP066667A (pt)
ES (1)	ES2303964T3 (pt)
HK (1)	HK1095831A1 (pt)
HR (1)	HRP20080272T3 (pt)
IL (1)	IL176457A (pt)
MX (1)	MXPA06007171A (pt)
NO (1)	NO337127B1 (pt)
NZ (1)	NZ548317A (pt)
PE (1)	PE20050758A1 (pt)
PL (1)	PL1725567T3 (pt)
PT (1)	PT1725567E (pt)
RU (1)	RU2383544C2 (pt)
SI (1)	SI1725567T1 (pt)
WO (1)	WO2005066183A1 (pt)
ZA (1)	ZA200606067B (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE10252667A1 (de)	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005016460A1 (de)	2005-04-11	2006-10-19	Grünenthal GmbH	Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006019597A1 (de)	2006-04-27	2007-10-31	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de)	2006-07-18	2008-01-24	Grünenthal GmbH	Spirocyclische Azaindol-Derivate
EP1894938A1 (en) *	2006-08-31	2008-03-05	Evonik Degussa GmbH	New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
DE102006046745A1 (de) *	2006-09-29	2008-04-03	Grünenthal GmbH	Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DE102007009235A1 (de) *	2007-02-22	2008-09-18	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102007009319A1 (de) *	2007-02-22	2008-08-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
ES2523580T3 (es)	2008-01-11	2014-11-27	Albany Molecular Research, Inc.	Piridoindoles substituidos con (1-Azinona)
BRPI0906467C1 (pt)	2008-01-25	2021-05-25	Gruenenthal Gmbh	forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
CA2719742C (en)	2008-03-27	2016-11-08	Gruenenthal Gmbh	Substituted spirocyclic cyclohexane derivatives
EP2280941B1 (de)	2008-03-27	2015-05-06	Grünenthal GmbH	(hetero-)aryl-cyclohexan-derivate
PT2271613E (pt) *	2008-03-27	2014-07-16	Gruenenthal Gmbh	Hidroximetilciclo-hexilamina
PE20121314A1 (es)	2008-03-27	2012-10-07	Gruenenthal Chemie	Derivados de 4-aminociclohexano sustituido
ES2621407T3 (es)	2008-03-27	2017-07-04	Grünenthal GmbH	Ciclohexildiaminas sustituidas
AU2009228643B2 (en) *	2008-03-27	2013-07-11	Grunenthal Gmbh	Spiro(5.5)undecane derivatives
LT2273983T (lt)	2008-05-09	2016-10-25	Grünenthal GmbH	Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
EP2356123B1 (en)	2008-11-13	2012-10-03	F.Hoffmann-La Roche Ag	Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
US8629158B2 (en) *	2009-07-01	2014-01-14	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003005A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
KR101747156B1 (ko)	2009-07-22	2017-06-27	그뤼넨탈 게엠베하	산화-안정화된 탬퍼-내성 용량형
TW201105316A (en)	2009-07-22	2011-02-16	Gruenenthal Gmbh	Hot-melt extruded pharmaceutical dosage form
UA107943C2 (en)	2009-11-16	2015-03-10	Lilly Co Eli	Compounds of spiropiperidines as antagonists of the orl-1 receptors
PT2501704E (pt) *	2009-11-16	2013-12-05	Lilly Co Eli	Compostos de espiropiperidina como antagonistas do receptor orl-1
SI3070091T1 (sl) *	2010-06-24	2019-08-30	Leo Pharma A/S	Derivati benzodioksola kot zaviralci fosfodiesteraze
TWI582092B (zh) *	2010-07-28	2017-05-11	歌林達股份有限公司	順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物
MX2013002377A (es)	2010-09-02	2013-04-29	Gruenenthal Gmbh	Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
RU2607499C2 (ru)	2010-09-02	2017-01-10	Грюненталь Гмбх	Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
RU2013114411A (ru)	2010-09-02	2014-10-10	Грюненталь Гмбх	Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
US8993765B2 (en)	2010-12-21	2015-03-31	Albany Molecular Research, Inc.	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
EA201400172A1 (ru)	2011-07-29	2014-06-30	Грюненталь Гмбх	Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EA201400173A1 (ru)	2011-07-29	2014-06-30	Грюненталь Гмбх	Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
MX353740B (es) *	2012-02-03	2018-01-26	Gruenenthal Gmbh	(1r,4r)-6´-fluoro-(n-metil- o n,n-dimetil-)-4-fenil-4´,9´-dihidro- 3´h-espiro-[ciclohexano-1,1´-pirano[3,4,b]indol]-4-amina para el tratamiento de fibromialgia y sindrome de fatiga cronica.
US20130225625A1 (en)	2012-02-28	2013-08-29	Grunenthal Gmbh	Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
JP6117249B2 (ja)	2012-02-28	2017-04-19	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
JP6282261B2 (ja)	2012-04-18	2018-02-21	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	不正使用防止および過量放出防止医薬剤形
SI2846835T1 (en)	2012-05-11	2018-01-31	Gruenenthal Gmbh	Heat-formed pharmaceutical dosage form, resistant to abuse and containing zinc
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US8912226B2 (en)	2012-05-18	2014-12-16	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US20130310435A1 (en)	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9308196B2 (en) *	2012-05-18	2016-04-12	Gruenenthal Gmbh	Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9320729B2 (en) *	2012-05-18	2016-04-26	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9345689B2 (en) *	2012-05-18	2016-05-24	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US9320725B2 (en) *	2012-05-18	2016-04-26	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US9855286B2 (en) *	2012-05-18	2018-01-02	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310385A1 (en)	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
SI2970284T1 (en)	2013-03-15	2018-02-28	Gruenenthal Gmbh	Crystalline cis- (E) -4- (3-fluorophenyl) -2 ', 3', 4 ', 9'-tetrahydro-N, N-dimethyl-2' - (1-oxo-3-phenyl-2-propenyl ) -spiro (cyclohexane-1,1 '(1H) -pyrido (3,4-b) indol) -4-amine
AU2014273227B2 (en)	2013-05-29	2019-08-15	Grunenthal Gmbh	Tamper-resistant dosage form containing one or more particles
AR096439A1 (es)	2013-05-29	2015-12-30	Gruenenthal Gmbh	Forma de dosificación resistente al uso indebido que contiene una o más partículas
CA2917136C (en)	2013-07-12	2022-05-31	Grunenthal Gmbh	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6480936B2 (ja)	2013-11-26	2019-03-13	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	クライオミリングによる粉末状医薬組成物の調製
WO2015091352A1 (en)	2013-12-16	2015-06-25	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion
AU2015261060A1 (en)	2014-05-12	2016-11-03	Grunenthal Gmbh	Tamper resistant immediate release capsule formulation comprising Tapentadol
EA201692388A1 (ru)	2014-05-26	2017-05-31	Грюненталь Гмбх	Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
TW201607923A (zh)	2014-07-15	2016-03-01	歌林達有限公司	被取代之氮螺環（４．５）癸烷衍生物
BR112017000762A2 (pt)	2014-07-15	2017-11-21	Gruenenthal Gmbh	derivados de azaspiro(4.5)decano substituído.
JP2018503693A (ja)	2015-02-03	2018-02-08	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	ポリエチレングリコールグラフトコポリマーを含む改変防止剤形
MX2017013637A (es)	2015-04-24	2018-03-08	Gruenenthal Gmbh	Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
CA2998259A1 (en)	2015-09-10	2017-03-16	Grunenthal Gmbh	Protecting oral overdose with abuse deterrent immediate release formulations
EP3481378A1 (en)	2016-07-06	2019-05-15	Grünenthal GmbH	Reinforced pharmaceutical dosage form

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663935A1 (fr) *	1990-06-27	1992-01-03	Adir	Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ508765A (en) *	1998-06-12	2003-10-31	Sod Conseils Rech Applic	Beta-carboline derivatives and pharmaceuticals thereof that selectively bind somatostatin receptor subtypes
CA2356269A1 (en) *	1998-12-24	2000-07-06	Yoshihisa Akiyama	Pain control agent
DE10044649A1 (de) *	2000-09-08	2002-07-04	Gruenenthal Gmbh	Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
DE10123163A1 (de) *	2001-05-09	2003-01-16	Gruenenthal Gmbh	Substituierte Cyclohexan-1,4-diaminderivate
DE10252667A1 (de) *	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate

2003
- 2003-12-23 DE DE10360792A patent/DE10360792A1/de not_active Withdrawn
2004
- 2004-12-21 WO PCT/EP2004/014539 patent/WO2005066183A1/de active IP Right Grant
- 2004-12-21 PT PT04804136T patent/PT1725567E/pt unknown
- 2004-12-21 BR BRPI0418052A patent/BRPI0418052A2/pt not_active Application Discontinuation
- 2004-12-21 ES ES04804136T patent/ES2303964T3/es active Active
- 2004-12-21 AU AU2004312147A patent/AU2004312147B2/en not_active Ceased
- 2004-12-21 DE DE502004006697T patent/DE502004006697D1/de active Active
- 2004-12-21 EP EP04804136A patent/EP1725567B1/de active Active
- 2004-12-21 CA CA2550868A patent/CA2550868C/en not_active Expired - Fee Related
- 2004-12-21 MX MXPA06007171A patent/MXPA06007171A/es active IP Right Grant
- 2004-12-21 PL PL04804136T patent/PL1725567T3/pl unknown
- 2004-12-21 SI SI200430663T patent/SI1725567T1/sl unknown
- 2004-12-21 CN CN2004800420360A patent/CN1922189B/zh not_active Expired - Fee Related
- 2004-12-21 NZ NZ548317A patent/NZ548317A/en not_active IP Right Cessation
- 2004-12-21 RU RU2006126787/04A patent/RU2383544C2/ru not_active IP Right Cessation
- 2004-12-21 KR KR1020067014815A patent/KR101152693B1/ko not_active IP Right Cessation
- 2004-12-21 JP JP2006546040A patent/JP4885733B2/ja not_active Expired - Fee Related
- 2004-12-21 DK DK04804136T patent/DK1725567T3/da active
- 2004-12-21 AT AT04804136T patent/ATE390430T1/de active
- 2004-12-22 AR ARP040104857A patent/AR047163A1/es not_active Application Discontinuation
- 2004-12-23 US US11/019,372 patent/US7332519B2/en not_active Expired - Fee Related
2005
- 2005-01-03 PE PE2005000023A patent/PE20050758A1/es not_active Application Discontinuation
2006
- 2006-06-21 IL IL176457A patent/IL176457A/en not_active IP Right Cessation
- 2006-06-21 EC EC2006006667A patent/ECSP066667A/es unknown
- 2006-07-21 ZA ZA200606067A patent/ZA200606067B/en unknown
- 2006-07-24 NO NO20063422A patent/NO337127B1/no not_active IP Right Cessation
2007
- 2007-02-23 HK HK07103179A patent/HK1095831A1/xx not_active IP Right Cessation
2008
- 2008-05-29 CY CY20081100557T patent/CY1107975T1/el unknown
- 2008-06-18 HR HR20080272T patent/HRP20080272T3/xx unknown

Also Published As

Publication number	Publication date
ATE390430T1 (de)	2008-04-15
HRP20080272T3 (en)	2008-09-30
US20050192333A1 (en)	2005-09-01
JP2007515446A (ja)	2007-06-14
PT1725567E (pt)	2008-05-09
IL176457A (en)	2013-11-28
DE502004006697D1 (de)	2008-05-08
ECSP066667A (es)	2006-10-25
EP1725567A1 (de)	2006-11-29
EP1725567B1 (de)	2008-03-26
KR101152693B1 (ko)	2012-06-15
MXPA06007171A (es)	2006-08-23
NO337127B1 (no)	2016-01-25
CY1107975T1 (el)	2013-09-04
PL1725567T3 (pl)	2008-09-30
JP4885733B2 (ja)	2012-02-29
CN1922189A (zh)	2007-02-28
CN1922189B (zh)	2010-06-16
ZA200606067B (en)	2007-10-31
RU2006126787A (ru)	2008-01-27
IL176457A0 (en)	2006-10-05
SI1725567T1 (sl)	2008-06-30
CA2550868C (en)	2012-03-06
HK1095831A1 (en)	2007-05-18
AR047163A1 (es)	2006-01-11
KR20070014117A (ko)	2007-01-31
PE20050758A1 (es)	2005-10-18
RU2383544C2 (ru)	2010-03-10
US7332519B2 (en)	2008-02-19
NZ548317A (en)	2010-01-29
DK1725567T3 (da)	2008-06-16
CA2550868A1 (en)	2005-07-21
DE10360792A1 (de)	2005-07-28
AU2004312147B2 (en)	2010-06-10
WO2005066183A1 (de)	2005-07-21
AU2004312147A1 (en)	2005-07-21
NO20063422L (no)	2006-09-25
ES2303964T3 (es)	2008-09-01

Legal Events

Date	Code	Title	Description
2017-04-04	B152	Others concerning applications: decision cancelled [chapter 15.32 patent gazette]
2017-06-13	B06G	Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
2017-08-29	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-10-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2018-12-18	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-04-09	B11B	Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements

Publication	Publication Date	Title
BRPI0418052A2 (pt)	2017-04-18	derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1
DE602006007563D1 (de)	2009-08-13	Agonisten
ATE549350T1 (de)	2012-03-15	Neuropeptid-2-rezeptor-agonisten
CR10689A (es)	2009-06-24	Anticuerpos humanos de alta afinidad para el receptor de il-4 humano
DE502004007253D1 (de)	2008-07-03	Kalibriervorrichtung
DK1948607T3 (da)	2010-07-26	Cyclopropylaminer med histamin-H3-receptormodulatorer
DE602005016150D1 (de)	2009-10-01	Flügelzellen-nockenwellenversteller
ZA200604791B (en)	2008-07-30	Hydronopol derivatives as agonists on human ORL1 receptors
DE502004003833D1 (de)	2007-06-28	Systemteil mit Bremsfeder
DE602005022800D1 (de)	2010-09-23	Schmiervorrichtung
DE102005043175B8 (de)	2010-03-04	Zylindervorrichtung
DE502005010285D1 (de)	2010-11-04	Zylinderanordnung mit einstellbarem Anschlag
DE602005007109D1 (de)	2008-07-10	Fahrzeugbeleuchtungsvorrichtung
DE502005006071D1 (de)	2009-01-08	Flügelzellen-nockenwellenversteller
DE602004005628D1 (de)	2007-05-16	Halterung mit mehreren Brücken
DK1853601T3 (da)	2009-05-18	Non-steroide glucocorticoid-receptormodulatorer
SE0400785L (sv)	2005-08-23	Kompenseringsanordning
ES1059370Y (es)	2005-07-16	Dispositivo de emergencia
DE502004008171D1 (de)	2008-11-13	Viskosekupplung
IL175347A0 (en)	2006-09-05	Hydronopol derivatives as agonists on human orl1 receptors
ES1061647Y (es)	2006-10-16	Dispositivo de elevacion para construccion.
ES1055051Y (es)	2004-01-16	Dispositivo para la construccion de basamentos
BRMU8402922Y1 (pt)	2012-12-25	bloco para fixaÇço de hidrâmetro .
ES1056673Y (es)	2004-08-01	Dispositivo de indicacion luminosa para usuarios de vehiculos.
ATA9842004A (de)	2005-10-15	Flügel